您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2016, Vol. 54 ›› Issue (7): 50-55.doi: 10.6040/j.issn.1671-7554.0.2016.058

• • 上一篇    下一篇

富血供肝脏转移瘤与肝细胞肝癌的能谱CT成像定量分析

岳倩倩1,王新怡2,杨志强2,姜舒2   

  1. 1.泰山医学院, 山东 泰安 271016;2.山东大学附属千佛山医院影像科, 山东 济南 250014
  • 收稿日期:2016-01-14 出版日期:2016-07-10 发布日期:2016-07-10
  • 通讯作者: 王新怡. E-mail:wxy_88@163.com E-mail:wxy_88@163.com
  • 基金资助:
    山东省科技攻关项目(2011GSFll828)

Quantitative analysis of spectral CT imaging on hypervascular hepatic metastasis and hepatocellular carcinoma

YUE Qianqian1, WANG Xinyi2, YANG Zhiqiang2, JIANG Shu2   

  1. 1. Taishan Medical University, Taian 271016, Shandong, China;
    2. Department of Radiology, Qianfoshan Hospital Affiliated to Shandong University, Jinan 250014, Shandong, China
  • Received:2016-01-14 Online:2016-07-10 Published:2016-07-10

摘要: 目的 探讨能谱CT成像定量分析在富血供肝脏转移瘤(HVHM)与肝细胞肝癌(HCC)鉴别诊断中的临床应用价值。 方法 分析行能谱CT扫描的肝脏恶性肿瘤患者47例,分为HVHM组(n=20)和HCC组(n=27),获取动脉期、门静脉期单能量图像,以及碘基图、水基图,测量病灶边缘明显强化区域、正常肝组织和腹主动脉的能谱参数,并计算标准化碘浓度(NIC)、病灶与正常肝组织碘浓度比值(LNR)、病灶动静脉期碘浓度差(ICD)及能谱曲线斜率,对上述参数行独立样本t检验和ROC曲线分析。 结果 动脉期HVHM组和HCC组的NIC、LNR、能谱曲线斜率无明显差异(P>0.05)。门静脉期HVHM组和HCC组NIC、LNR及能谱曲线斜率差异有统计学意义(P<0.05):两组门静脉期NIC分别为0.59±0.08、0.45±0.10;LNR分别为1.17±0.22、0.92±0.16;能谱曲线斜率分别为1.85±0.49、1.18±0.34。HVHM组和HCC组ICD参数分别为(0.54±0.39)g/L、(0.45±0.39)g/L,差异无统计学意义(P>0.05)。水(碘)浓度在动脉期、门静脉期差异无统计学意义(P>0.05)。门静脉期能谱曲线斜率对HVHM组和HCC组的鉴别诊断效能最高。 结论 HVHM和HCC在门静脉期的能谱CT特征性物质含量及能谱曲线具有明显差异,CT能谱成像为HVHM和HCC鉴别诊断提供了一种多参数定量分析方法。

关键词: 肝脏转移瘤, 富血供, 能谱成像, X线计算机, 肝细胞肝癌, 体层摄影术, 定量分析

Abstract: Objective To evaluate the value of the spectral CT quantitative analysis in the differential diagnosis of hypervascular hepatic metastasis(HVHM)and hepatocellular carcinoma(HCC). Methods A total of 47 patients with hepatic malignant tumors undergoing spectral CT scan were divided into HVHM group(n=20)and HCC group(n=27). The monochromatic image sets, iodine-based material decomposition images and water-based material decomposition images were obtained, and the spectral parameters of lesions, normal hepatic tissues and aorta were measured. Then the normalized iodine concentrations(NIC), lesion-normal parenchyma iodine concentration ratio(LNR), iodine concentration difference(ICD)between the arterial phase and portal venous phase, and the slope of spectral curve were calculated. Independent samples t test and ROC were applied to analyze the quantitative parameters. Results Differences of the NIC, LNR and slope of spectral curve were not statistically significant(P>0.05)during arterial phase. Statistically significant differences of the NIC, LNR and slope of spectral curve were found between the HVHM 山 东 大 学 学 报 (医 学 版)54卷7期 -岳倩倩,等.富血供肝脏转移瘤与肝细胞肝癌的能谱CT成像定量分析 \=-group and the HCC group(P<0.05)during portal venous phase: NIC=0.59±0.08, 0.45±0.10; LNR=1.17±0.22, 0.92±0.16; the slopes of spectral curve=1.85±0.49, 1.18±0.34, respectively. Differences of ICD between the HVHM group and the HCC group were not statistically significant(P>0.05), and ICD were(0.54±0.39)g/L,(0.45±0.39)g/L, respectively. Differences of water(iodine)concentration in arterial and portal venous phase between the lesions were not statistically significant(P>0.05). The slope of spectral curve in the portal venous phase had the highest diagnostic efficiency in differentiating HVHM from HCC. Conclusions HVHM and HCC have different spectral characteristic parameters and spectral curves during portal venous phase. Spectral CT imaging provides a new multi-parameter quantitative analysis imaging method for differentiating HVHM and HCC.

Key words: Hepatic metastasis, Hypervascularity, Tomography, X-ray computed, Quantitative analysis, Spectral imaging, Hepatocellular carcinoma

中图分类号: 

  • R445
[1] Namasivayam S, Salman K, Mittal P, et al. Hypervascular hepatic focal lesions: spectrum of imaging features[J]. Curr Probl Diagn Radiol, 2007, 36(3): 107-123.
[2] 周康荣. 中华影像医学: 肝胆胰脾卷[M]. 北京: 人民卫生出版社, 2002: 67.
[3] Christine S, Stephen T, Ivancevic MK, et al. Diffusion-weighted MRI of metastatic liver lesions: is there a difference between hypervascular and hypovascular metastases?[J]. Acta Radiol, 2014, 55(5): 515-523.
[4] Matos AP, Altun E, Ramalho M, et al. An overview of imaging techniques for liver metastases management[J]. Expert Rev Gastroenterol Hepatol, 2015, 9(12): 1561-1576.
[5] Bhayana D, Kim TK, Jang HJ, et al. Hypervascular liver masses on contrast-enhanced ultrasound: the importance of washout[J]. AJR Am J Roentgenol, 2010, 194(4): 977-983.
[6] Chae EJ, Song JW, Krauss B, et al. Clinical utility of dual-energy CT in the evaluation of solitary pulmonary nodules: initial experience[J]. Radiology, 2008, 249(2): 671-681.
[7] 刘金刚, 刘亚, 李丽新, 等. CT能谱成像在诊断肿瘤淋巴结转移和肿瘤性质中的作用[J]. 中华放射学杂志, 2011, 45(8): 731-735. LIU Jingang, LIU Ya, LI Lixin, et al. Preliminary study of spectral CT imaging in the differential diagnosis of metastatic lymphadenopathy due to various tumors[J]. Chin J Radiol, 2011, 45(8): 731-735.
[8] Paul J, Vogl TJ, Mbalisike EC. Oncological applications of dual-energy computed tomography imaging[J]. J Comput Assist Tomogr, 2014, 38(6): 834-842.
[9] 陈赜, 张志勇, 赵霄, 等. 269例肝转移瘤血管造影影像分析[J]. 吉林医学, 2010, 31(25): 4360-4361.
[10] Lv P, Lin XZ, Li J, et al. Differentiation of small hepatic hemangioma from small hepatocellular carcinoma: recently introduced spectral CT method[J]. Radiology, 2011, 259(3): 720-729.
[11] Yu Y, He N, Sun K, et al. Differentiating hepatocellular carcinoma from angiomyolipoma of the liver with CT spectral imaging: a preliminary study[J]. Clin Radiol, 2013, 68(9): 491-497.
[12] Voboril R. Blood supply of metastatic liver tumors: an experimental study[J]. Int Surg, 2005, 90(2): 71-77.
[13] Semelka RC, Hussain SM, Marcos HB, et al. Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findings-initial observations[J]. Radiology, 2000, 215(1): 89-94.
[14] Hayano K, Desai GS, Kambadakone AR, et al. Quantitative characterization of hepatocellular carcinoma and metastatic liver tumor by CT perfusion[J]. Cancer Imaging, 2013, 13(4): 512-519.
[15] 薛敏娜, 白人驹, 李丰坦, 等. CT灌注成像对原发性肝癌、肝转移瘤和肝血管瘤的鉴别诊断价值[J]. 国际放射学杂志, 2008, 31(3): 152-155. XUE Minna, BAI Renju, LI Fengtan, et al. Differential value of CT perfusion imaging in hepatocellular carcinomas, hepatic metastastes and hemoangiomas[J]. Int J Med Radiol, 2008, 31(3): 152-155.
[16] Wei W, Yu Y, Lv W, et al. Predictive value of dual-energy spectral computed tomographic imaging on the histological origin of carcinomas in the ampullary region[J]. Abdom Imaging, 2014, 39(4): 702-710.
[17] Wang Q, Shi G, Qi X, et al. Quantitative analysis of the dual-energy CT virtual spectral curve for focal liver lesions characterization[J]. Eur J Radiol, 2014, 83(10): 1759-1764.
[1] 王玉红,张丽红,王林省,陈月芹,王彦辉,王皆欢,李传福. 消化道颗粒细胞瘤的影像学表现[J]. 山东大学学报(医学版), 2017, 55(8): 66-70.
[2] 李扬,何闯,陈玉潇,杨丽,李良山,李廷源,黄学全. 放射性125I粒子植入近距离治疗长骨转移瘤的临床疗效[J]. 山东大学学报(医学版), 2017, 55(2): 50-54.
[3] 谷旭, 王夏青, 任万华, 秦成勇, 韩国庆. NPRL2、Survivin在肝细胞肝癌中的表达及其临床意义[J]. 山东大学学报(医学版), 2015, 53(6): 68-72.
[4] 张苗苗, 王建荣, 刘伟. 原发性开角型青光眼患者与正常人黄斑区脉络膜厚度的比较[J]. 山东大学学报(医学版), 2015, 53(2): 71-74.
[5] 何东添, 李晓平, 李尚仁. 多层螺旋CT对比彩色多普勒超声在甲状腺微小结节鉴别诊断中的应用[J]. 山东大学学报(医学版), 2014, 52(Z1): 140-141.
[6] 王小林, 王虎, 何发清, 郭兵文. 肝细胞癌经导管肝动脉化疗栓塞术治疗后 CT检查与评价[J]. 山东大学学报(医学版), 2014, 52(S2): 74-75.
[7] 谢超贤, 龙腾河, 廖明壮. MSCT在主动脉壁间血肿和 穿透性动脉硬化性溃疡的诊断价值[J]. 山东大学学报(医学版), 2014, 52(S2): 123-125.
[8] 于永梅, 张华, 朱建辉, 王文成, 郭美玲. 128层4DCT全肝灌注成像在肝肿瘤诊断中的价值[J]. 山东大学学报(医学版), 2014, 52(7): 66-70.
[9] 姜舒1,姜召福2,王新怡1,杨志强1,张经建1. CT能谱成像鉴别门静脉良恶性栓子的初步探讨[J]. 山东大学学报(医学版), 2014, 52(6): 81-84.
[10] 刘常绪, 张成琪, 王新怡, 杨志强. 能谱CT在肝细胞癌与肝内肿块型胆管细胞癌鉴别诊断中的应用价值[J]. 山东大学学报(医学版), 2014, 52(12): 94-98.
[11] 李恒1, 李哲1, 乔晓俊1,高爱琴2, 张楠2. 中心体α-微管蛋白、P53蛋白及端粒酶在原发性肝癌中的表达及相关性[J]. 山东大学学报(医学版), 2013, 51(8): 74-77.
[12] 刘妍,刘聪聪,时丹丹,孙霄,李杰. 声触诊组织定量分析在肾移植术后慢性移植肾肾病诊断中的价值[J]. 山东大学学报(医学版), 2013, 51(8): 78-81.
[13] 王林省1,张丽红2,陈月芹1,孙占国1,王皆欢1,王玉红1,李慧1,李传福3. 含脂肪肾上腺良性肿瘤的CT表现[J]. 山东大学学报(医学版), 2013, 51(3): 99-103.
[14] 鲁东,吕维富,张正峰,王伟昱,侯昌龙,张行明,肖景坤,周春泽. MSCTA在肝癌介入治疗术前的应用价值[J]. 山东大学学报(医学版), 2012, 50(9): 100-.
[15] 杜林娜1,郭泾2. 口腔矫治器治疗OSAS有效者和无效者的比较[J]. 山东大学学报(医学版), 2012, 50(8): 120-123.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!